S. Speckart

发表

Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody.

G. Gleich, B. Cutter, L. Wagner, 2009, The Journal of allergy and clinical immunology.

Leukemic reticuloendotheliosis: "hairy cell leukemia," functional and structural features of the abnormal cell in a patient with profound leukocytosis.

R. Macdermott, G. S. Nash, D. Boldt, 1977, Blood.

Alterations in platelet surface sialytransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis.

M. Haut, S. Scialla, S. Speckart, 1979, Cancer research.

Interactions of plant lectins with glycolipids in liposomes

C. Alving, R. Richards, D. Boldt, 1977 .

Excretion of DNA by purified human lymphocyte subpopulations.

R. Macdermott, G. S. Nash, D. Boldt, 1977, Journal of immunology.

Chronic lymphatic leukemia (CLL): Cell surface changes detected by lectin binding and their relation to altered glycosyltransferase activity

R. Macdermott, D. Boldt, S. Speckart, 1978 .

Chronic lymphatic leukemia (CLL): cell surface changes detected by lectin binding and their relation to altered glycosyltransferase activity.

R. Macdermott, D. Boldt, S. Speckart, 1978, Blood.

Different effects of concanavalin A and E-phytohemagglutinin upon lymphocyte glycosyltransferase activities.

D. Boldt, S. Speckart, K. Ryerson, 1978, Cancer research.

Cell surface changes in transformed human lymphocytes. I. Con A and E-PHA induced unique changes in surface topography.

D. Boldt, S. Speckart, K. Ryerson, 1978, Experimental cell research.